Maintenance chemotherapy and cure of childhood acute lymphoblastic leukaemia (Q68323379)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1682696%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Maintenance chemotherapy and cure of childhood acute lymphoblastic leukaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1682696%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

R. P. Gale

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682696

28 October 2022

A. Butturini

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682696

28 October 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1682696%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

23 November 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1682696

full work available at URL

28 October 2022

https://api.elsevier.com/content/article/PII:014067369192604Z?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

https://api.elsevier.com/content/article/PII:014067369192604Z?httpAccept=text/plain

28 October 2022

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

28 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1682696%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1682696%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

8778

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1682696%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

1315-1318

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1682696%20AND%20SRC:MED&resulttype=core&format=json

Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia

23 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group.

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Curing children of leukemia

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Drug dosage and remission duration in childhood lymphocytic leukemia

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Interrupted vs. continued maintenance therapy in childhood acute leukemia

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Gene amplification and drug resistance in cultured murine cells.

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Interplay between the toxic effects of anticancer drugs and host antitumor immunity in cancer therapy

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Immunosuppression and serious infections in children with acute lymphoblastic leukaemia: a comparison of three chemotherapy regimes

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Long-term abnormalities in T and B lymphocyte function in children following treatment for acute lymphoblastic leukaemia

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Spontaneous natural killer cell activity in childhood acute lymphoblastic leukaemia

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

To B, or not to B: that is the question

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Somatic generation of antibody diversity

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. United Kingdom Children's Cancer Study Group (UKCCSG)

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

Detection of minimal residual disease in childhood leukemia with the polymerase chain reaction

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92604-Z

28 October 2022

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1682696%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1682696%20AND%20SRC:MED&resulttype=core&format=json